Over the past 12 months, China’s neo-protein sector has entered a new phase of policy-driven acceleration, marked by stronger national strategic positioning, expanding public R&D support, and increasing regulatory openness. From central planning frameworks to provincial action plans and innovation platforms, a multi-level policy system is rapidly taking shape, laying the foundation for the transition of neo-proteins from early-stage innovation to large-scale industrialization and commercialization.
This summary, prepared by the ProVeg China team, highlights key policy and industry developments in China’s neo-protein sector from mid-2025 to mid-2026, with a focus on human food applications. It is intended to serve as a reference for colleagues, partners, and those following the development of China’s neo-protein sector.
Executive Summary:
China’s neo-protein industry has entered a decisive phase of policy-driven acceleration. Since mid-2025, the central government has moved from exploratory research to active industrial deployment, with the 15th Five-Year Plan (2026-2030) officially mandating ‘active development of synthetic biology and expansion of new protein sources.’
Key policy trends and developments are as follows:
- National policy: China 15th Five-Year Plan has elevated the neo-protein sector to a national strategic priority.
- Public R&D funding: The National Natural Science Foundation of China (NSFC) has designated neo-protein as an encouraged area for applications in its 2026 funding.
- Regulation approval: State openness toward novel protein resources has increased, with more than 10 neo-protein-related food ingredients receiving national regulatory approval.
- New R&D Facility Investment: Two major R&D facilities have been established under a government–academia–industry collaborative model.
Key Trends and Developments:
1. Policy Support for Neo-Protein Continues to Strengthen
1.1 Neo-Protein Is Becoming Part of China’s National Development Strategy
The strongest signal comes from the Recommendations of the Central Committee of the Communist Party of China for Formulating the 15th Five-Year Plan for National Economic and Social Development, released in March 2026 as a guiding framework for China’s next development stage. It explicitly calls for the active development of synthetic biology and the expansion of new protein sources as part of efforts to build a diversified food supply system, elevating the neo-protein sector to a national strategic priority.
This is highly significant because China’s Five-Year Plans shape national industrial priorities, public funding allocation, local government investment direction and state-backed innovation programs. This marks the first time that neo-protein has been explicitly incorporated into a national Five-Year Plan, providing a highly strategic policy window and strong directional guidance for the industry’s development.
1.2 Neo-protein Enters China’s Consumption Policy Agenda and Foreign Investment Catalogue
In July 2025, the Implementation Plan on Promoting Agricultural Product Consumption (2025) signaled a clear policy shift by integrating neo-protein development into China’s broader food consumption and market development agenda. It explicitly supports R&D collaboration between food enterprises and research institutions on emerging food ingredients, including microbial protein. This marks neo-protein as an increasingly recognized component in driving consumption growth and upgrading the food system.
In the Catalogue of Encouraged Foreign Investment Industries (2025 Edition), effective February 1, 2026, explicitly includes “development and production of plant-based protein imitation meat foods” in its encouraged category. Eligible projects can therefore access concrete incentives, including tariff exemptions on imported equipment and tax benefits.
1.3 An increasing number of major cities are accelerating the development of neo-protein.
A defining feature of the 2025–2026 period is the rapid acceleration of local policy activity, with multiple cities and provinces introducing dedicated policies and clear targets for neo-proteins, synthetic biology, and future foods. Local governments are no longer merely implementing central directives, but are actively positioning themselves as national pilot models through a wide range of policy tools.
Regionally, at least six provinces and cities have released dedicated action plans for the neo-protein sector or highlighted neo-protein as a priority development area, including Beijing, Shanghai, Shandong Provenience, Heilongjiang Province, Guangdong Province and Shenzhen.
Main Regional Action Plans in China (Mid-2025 to Mid-2026)
| Region | Policy Name | Releasa time | Core policies |
| 1Pinggu District of Beijing | Action Plan for Accelerating Innovative Development of the Alternative Protein Industry in Pinggu District, Beijing (2025-2027) | By 2027, Pinggu District aims to advance its position in alternative proteins by developing 2–3 breakthrough technologies, at least 8 proprietary microbial or algal strains, key R&D and pilot-scale platforms, and 10 innovative products, while attracting over 12 enterprises and building an integrated industrial park. The sector is expected to reach around RMB 1 billion in output value, alongside an international exchange platform and globally competitive Beijing-branded products, positioning Pinggu as a national leader in alternative protein innovation and a leading industrial cluster in China. | |
| Shandong Province | Shandong Province Action Plan for Technological Innovation in the Modern Food Industry (2026–2028) | November, 2025 | The plan prioritizes neo proteins in food innovation, advancing microbial, plant-based, and cell-cultured proteins through synthetic biology, precision fermentation, and bio-manufacturing. It supports functional protein ingredients, meat and dairy alternatives, scalable production platforms, and the conversion of food byproducts into protein ingredients, while promoting industrialization and full-chain development from R&D to commercialization. |
| Shanghai | Action Plan of Shanghai Municipality on Accelerating Food Technology Innovation to Empower Industrial Development (2026–2030) | December, 2025 | Support the R&D of novel foods by advancing research in alternative proteins, cultured meat, cultured milk, 3D-printed foods, algae, and other emerging food categories. By 2027, achieve major breakthroughs in the development of synthetic biology-based foods, and successfully develop and obtain approval for 3–5 “Three New Foods” products (new food ingredients, new varieties of food additives, and new types of food-related products). |
| Heilongjiang Province | Implementation Measures for the Incentive Policy on the Development of Novel Foods in Heilongjiang Province | March, 2026 | Encourage the development of novel foods and ingredients, including microbial proteins, probiotics, and plant-based alternative proteins. A one-time reward of RMB 2 million will be granted for each novel food product that passes national approval and obtains a license. |
| Guangdong Province | Measures of Guangdong Province to Promote Biomanufacturing Empowering the Manufacturing Industry | January, 2026 | Support the R&D and industrialization of neo protein. Provincial manufacturing innovation centers working on neo protein related R&D projects can receive up to ¥10 million in funding; Standardize the R&D and industrialization of neo-protein-related products and promote their compliant market entry. |
| Shenzhen | Measures of Shenzhen Municipality to Promote Synthetic Biology Innovation and Lead the High-Quality Development of the Biomanufacturing Industry | April, 2026 | Support key technological breakthroughs in strategic areas by advancing the application of synthetic biology in new product development across food, agriculture, healthcare, cosmetics, advanced materials, and green, low-carbon sectors. Mission-driven “leading-edge” projects may receive funding of up to RMB 30 million per project, while major initiatives in systems, engineering, equipment, and strategic research may be supported with up to RMB 100 million per project. |
1.4 China is accelerating the approval of neo-proteins as novel food ingredients
Since mid-2025, more than 10 neo-protein-related food ingredients have received national regulatory approval in China, including Fusarium venenatum and Saccharomyces cerevisiae. These approvals mark a key milestone in the regulatory development of neo-proteins, indicating that neo-protein have moved beyond pilot evaluation into a more formalized approval framework. The state’s growing openness toward novel protein resources, together with the accelerated approval process for novel protein ingredients, has significantly strengthened the regulatory and market access foundation for local industrial development and commercialization.
As highlighted in the 2026 China Neo-Protein Innovation and Development Index (Wuxi Index), China’s policy environment is entering a more implementation-oriented phase, with stronger coordination across regulation, industrial development, and innovation support mechanisms. Overall, the current policy environment has reached a new level in terms of breadth, depth, and strategic significance, and is expected to accelerate the transition of neo-protein from pilot-stage exploration to large-scale industrialization and commercialization.
2. Neo-Proteins Gaining Increasing Priority in China’s Public R&D Funding System
Since 2026, neo-proteins have begun to be increasingly recognized as an emerging priority in China’s public funding system, marking a clear shift toward stronger policy support for the field. In February 2026, the National Natural Science Foundation of China (NSFC) included neo-proteins as a key funding area, signaling growing national-level attention.
At the regional level, Shanghai, Jiangsu Province and Shenzhen has also highlighted neo-protein research as priorities in their 2026 public fund programs.
Overall, this reflects the gradual but clear mainstreaming of neo-proteins into both national and provincial public R&D funding frameworks.
3. Innovation platforms: A multi-stakeholder ecosystem spanning the full industry–academia–research value chain is taking shape.
Since mid-2025, two major R&D facilities have been established, including the Neo-Protein Biomanufacturing Innovation Center in Wuxi, co-founded by SDIC, the Wuxi Municipal Government, and Jiangnan University, signaling strong strategic commitment and growing state investment momentum in the neo-protein sector. In Beijing, the Neo-Protein Resource Exploration and Utilization Industry Research Institute was jointly established by Beijing Technology and Business University, the Pinggu District Government, the China National Research Institute of Food and Fermentation Industries, and enterprises, further highlighting a government–academia–industry collaborative model in neo-protein development.
Outlook:
Over the past 12 months, China’s policy environment for neo-proteins has become significantly more supportive. With neo-proteins now incorporated into national strategic planning and backed by growing public investment, regulatory progress, and local government initiatives, the foundations for long-term industry growth are rapidly taking shape.
Despite strong policy tailwinds, the neo-protein industry still faces several structural challenges. Key technical bottlenecks remain in scaling laboratory-stage innovation into cost-effective industrial production, particularly in areas such as strain development, fermentation scale-up, downstream processing, product quality, and commercialization. Regulatory frameworks for novel ingredients are still evolving. In addition, consumer awareness and trust remain limited, with ongoing concerns around safety, naturalness and acceptance, resulting in relatively few products successfully achieving large-scale commercialization and sustained market adoption.
At ProVeg China, we look forward to continuing to work with partners across the ecosystem to support innovation, strengthen collaboration between different stakeholders, and help advance the development of neo-proteins as part of a more sustainable and resilient food system.
Reference:
- https://www.gov.cn/yaowen/liebiao/202603/content_7062633.htm
- https://www.gov.cn/zhengce/zhengceku/202507/content_7034022.htm
- https://www.bjpg.gov.cn/pgqrmzf/zwxx0/zcjd30/wzjd/1084474/index.html
- https://www.nsfc.gov.cn/p1/2931/3971/3972/qy2026.html
- 2026 China Neo-Protein Innovation and Development Index (Wuxi Index)
- 山东省科学技术厅 政策发布 关于印发《山东省现代食品产业科技创新行动计划（2026—2028年）》的通知
- 2026年4月-市科技创新局-市发展改革委-市市场监管局-市卫生健康委关于印发《深圳市推动合成生物创新引领生物制造产业高质量发展若干措施》的通知.pdf
- https://www.shanghai.gov.cn/gwk/search/content/be71abafe631407e80d4c37f3f3ab264
- https://gxt.hlj.gov.cn/gxt/c106958/202603/c00_31927036.shtml
- https://kjc.seu.edu.cn/_upload/article/files/35/7a/463fc6bd4e24afa068e22a650ba2/ef6c53a4-f8ec-4e72-9dcb-bd658eb4d5e6.pdf
- 我国第二款微生物蛋白获批，重构中国蛋白新势力_镰刀_威尼斯_真菌
- 上海市科学技术委员会关于发布2026年度关键技术研发计划“食品科技”项目申报指南的通知_项目申报_上海市科学技术委员会
- https://www.ndrc.gov.cn/xxgk/zcfb/fzggwl/202512/P020251224301773999332.pdf
- 广东省工业和信息化厅 广东省发展和改革委员会关于印发《广东省推动生物制造赋能制造业的若干措施》的通知 | 广东省工业和信息化厅
- 深圳市科技创新局关于征集2026年度深圳市重点产业研发计划备选课题的通知-通知公告-深圳市科技创新局网站
